[1]
“POTENCY TEST OF COMMERCIALLY AVAILABLE INACTIVATED NEWCASTLE DISEASE VACCINES IN SERBIA”, AVM, vol. 7, no. 2, pp. 111–121, Jan. 2015, doi: 10.46784/e-avm.v7i2.136.